Can acotinib/acalabrutinib and painkillers be used at the same time?

Acalabrutinib, also known as acalabrutinib (Acalabrutinib), is a new generation Bruton tyrosine kinase inhibitor (BTKi) that has become the drug of choice in the treatment of chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It is also used to treat adult patients with mantle cell lymphoma (MCL) who have undergone one or more treatments. The working principle of acotinib is to inhibit the activity of BTK enzyme and block abnormal signaling pathways in leukemia or lymphoma cells, thereby curbing the growth and spread of tumors. Thanks to its unique mechanism of action, acotinib has demonstrated excellent efficacy and high safety in clinical trials.

However, patients receiving this treatment sometimes experience adverse effects associated withBTKi treatment. Therefore, we must be extremely cautious when considering use in combination with other medications. Drug-drug interactions may affect the metabolism, absorption, and excretion of drugs, thereby changing the effects of the drug or increasing the risk of adverse reactions. Acotinib may interact with a variety of medications, both prescription and over-the-counter.

For patients taking acotinib, can they take painkillers at the same time? Taking the common analgesic ibuprofen as an example, taking acotinib and ibuprofen at the same time may increase the risk of bleeding. In fact, in clinical studies, acotinib use alone has been associated with serious and even fatal bleeding events. Therefore, patients should seek immediate medical help if they experience any unusual bleeding, bruising, or symptoms such as dizziness, dizziness, bloody stools, coughing up blood, or bloody vomit. And patients should not stop taking any medicine without talking to their doctor.